EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

The molecular characteristics of recurrent/metastatic HPV ‐positive head and neck squamous cell carcinoma: A systematic review of the literature

Susanne Flach iD, Pavithran Maniam iD, Shi Ying Hey, Jaiganesh Manickavasagam

Clinical Otolaryngology · 2024

DOI: 10.1111/coa.14161 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Otolaryngology, 2024. Verfasst von Susanne Flach und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, LMU Klinikum, Munich, Germany. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Neoplasm Recurrence, Local, Papillomavirus Infections, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

About 17% of patients with human papillomavirus (HPV)‐positive head and neck squamous cell carcinoma (HNSCC), which is mainly comprised of oropharyngeal SCC (OPSCC), will experience disease recurrence, which is often considered incurable when manifested at a metastatic and/or recurrent stage. We conducted a critical qualitative systematic review. Our objectives were to provide an overview of the molecular landscape of recurrent/metastatic HPV‐positive HNSCC as well as novel molecular biomarkers.

Design

A literature review was conducted to identify studies reporting on the molecular characteristics of recurrent/metastatic HPV‐positive HNSCC, novel molecular biomarkers and treatment options. The reviews of abstracts, full articles, and revision of the included studies, followed by data extraction and quality assessment were performed by three independent assessors. All primary literature, such as retrospective, prospective, and clinical trials as well as basic research studies were considered, and the final search was conducted at the end of February 2023. The level of evidence was rated using the guidelines published by the Oxford Centre for Evidence‐based Medicine and quality was assessed using the Newcastle‐Ottawa Scale criteria. Results and Conclusions The literature search resulted in the identification of 1991 articles. A total of 181 full articles were screened, and 66 articles were included in this analysis. Several studies reported that recurrent/metastatic HPV‐positive HNSCC had higher rates of TP53 mutation and were genomically similar to HPV‐negative HNSCC. The detection of circulating tumour tissue‐modified HPV DNA (ctHPVDNA) as a specific biomarker has shown promising results for monitoring treatment response and recurrence in the subset of HPV‐positive HNSCC. In addition, evidence for targeted therapy in recurrent/metastatic HPV‐positive HNSCC has emerged, including agents that inhibit overexpressed EGFR . Studies of combination immunotherapy are also underway. Our review outlines the latest evidence on the distinct molecular profiles of recurrent/metastatic HPV‐positive HNSCC as well as the clinical potential of ctHPVDNA testing in routine practice. More controlled and longitudinal studies are needed to identify additional molecular targets and to assess the performance and benefits of novel molecular biomarkers in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsNeoplasm Recurrence, LocalPapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckHumansBiomarkers, TumorPapillomaviridae

Stichwörter der Autor:innen

HPVhead and neck neoplasmhead and neck squamous cell carcinomametastaticrecurrent

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, LMU Klinikum, Munich, Germany.
  • German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Department of Otolaryngology, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Department of Otolaryngology & Head and Neck Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Department of Otorhinolaryngology and Head & Neck Surgery and Tayside Medical Sciences Centre, Ninewells Hospital, Dundee, UK.
  • School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.

ORCID-Profile: Susanne Flach, Pavithran Maniam

Zitieren

APA

Flach, S., Maniam, P., Hey, S. Y., & Manickavasagam, J. (2024). The molecular characteristics of recurrent/metastatic HPV ‐positive head and neck squamous cell carcinoma: A systematic review of the literature. Clinical Otolaryngology. https://doi.org/10.1111/coa.14161

Vancouver

Flach S, Maniam P, Hey SY, Manickavasagam J. The molecular characteristics of recurrent/metastatic HPV ‐positive head and neck squamous cell carcinoma: A systematic review of the literature. Clinical Otolaryngology. 2024. doi:10.1111/coa.14161

BibTeX
@article{Flach2024,
  author = {Flach, Susanne and Maniam, Pavithran and Hey, Shi Ying and Manickavasagam, Jaiganesh},
  title = {The molecular characteristics of recurrent/metastatic HPV ‐positive head and neck squamous cell carcinoma: A systematic review of the literature},
  journal = {Clinical Otolaryngology},
  year = {2024},
  doi = {10.1111/coa.14161}
}
Kostenlos starten →